MiR-218-5p can specifically bind to lipoma HMGIC fusion partner-like 3 (LHFPL3) mRNA, resulting in inhibition of EMT, decreased cellular activity, proliferation, and invasive capacity [76]. Here, LHFPL3 is linked to lipoma.